H. Spearman

发表

Vitamin D Receptor Expression in Plasmablastic Lymphoma and Myeloma Cells Confers Susceptibility to Vitamin D

A. Banham, F. Buffa, E. Soilleux, 2016, Endocrinology.

Diverse molecular mechanisms involved in AChR deficiency due to rapsyn mutations.

J. Palace, A. Vincent, J. Cossins, 2006, Brain : a journal of neurology.

erythropoietin gene therapy Long-term reversal of chronic anemia using a hypoxia-regulated

R. Ali, P. Maxwell, H. Spearman, 2013 .

Long-term reversal of chronic anemia using a hypoxia-regulated erythropoietin gene therapy.

R. Ali, P. Maxwell, M. de Alwis, 2002, Blood.

Characterization of physiologically regulated vectors for the treatment of ischemic disease.

A. Kingsman, K. Boast, H. Spearman, 1999, Human gene therapy.

Dok-7 Mutations Underlie a Neuromuscular Junction Synaptopathy

J. Palace, Hanns Lochmüller, A. Vincent, 2006, Science.

The Forkhead Transcription Factor FOXP2 Is Required for Regulation of p21 in 143B Osteosarcoma Cell Growth Arrest

S. Fisher, A. Banham, P. Croucher, 2020 .

Hypoxia-mediated tumour targeting

H. Spearman, S. Kingsman, Denise M. Day, 2003, Gene Therapy.

Mutation analysis of CHRNA1, CHRNB1, CHRND, and RAPSN genes in multiple pterygium syndrome/fetal akinesia patients.

S. Vermeer, J. Cossins, D. Beeson, 2008, American journal of human genetics.

N-terminally truncated FOXP1 protein expression and alternate internal FOXP1 promoter usage in normal and malignant B cells

S. Barrans, A. Banham, P. Brown, 2016, Haematologica.

Mutations Causing DOK7 Congenital Myasthenia Ablate Functional Motifs in Dok-7*

T. Natsume, S. Iemura, D. Beeson, 2008, Journal of Biological Chemistry.

FOXP1 suppresses immune response signatures and MHC class II expression in activated B-cell-like diffuse large B-cell lymphomas

A. Banham, M. Møller, M. Møller, 2015, Leukemia.

FOXP 1 suppresses immune response signatures and MHC class II expression in activated B-cell-like diffuse large B-cell lymphomas

M. Møller, L. Lyne, H. Spearman, 2016 .

Syddansk Universitet FOXP 1 suppresses immune response signatures and MHC class II expression in activated B-cell-like diffuse large B-cell lymphomas

M. Møller, L. Lyne, H. Spearman, 2016 .

The Forkhead Transcription Factor FOXP2 Is Required for Regulation of p21WAF1/CIP1 in 143B Osteosarcoma Cell Growth Arrest

S. Fisher, A. Banham, P. Croucher, 2015, PloS one.

FOXP2-positive diffuse large B-cell lymphomas exhibit a poor response to R-CHOP therapy and distinct biological signatures

A. Banham, M. Møller, E. Soilleux, 2016, Oncotarget.

A novel congenital myasthenic syndrome due to decreased acetylcholine receptor ion-channel conductance.

K. Tai, M. Sansom, D. Beeson, 2012, Brain : a journal of neurology.

Congenital Myasthenic Syndromes and the Formation of the Neuromuscular Junction

Jacqueline Palace, A. Vincent, J. Cossins, 2008, Annals of the New York Academy of Sciences.

Direct retroviral delivery of human cytochrome P450 2B6 for gene-directed enzyme prodrug therapy of cancer

Andrew Slade, Mark Uden, M. Uden, 2001, Cancer Gene Therapy.